David P Kao, James Martin, Christina Aquilante, Elise L Shalowitz, Katarina Leyba, Elizabeth Kudron, Jane EB Reusch, Judith G. Regensteiner
{"title":"向美国食品药品管理局报告他汀类药物相关糖尿病的性别差异","authors":"David P Kao, James Martin, Christina Aquilante, Elise L Shalowitz, Katarina Leyba, Elizabeth Kudron, Jane EB Reusch, Judith G. Regensteiner","doi":"10.1101/2024.05.01.24306727","DOIUrl":null,"url":null,"abstract":"<strong>Objective</strong> Determine whether statin-associated DM is reported more frequently in women than men in post-marketing adverse drug event (ADE) surveillance.","PeriodicalId":501419,"journal":{"name":"medRxiv - Endocrinology","volume":"60 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration\",\"authors\":\"David P Kao, James Martin, Christina Aquilante, Elise L Shalowitz, Katarina Leyba, Elizabeth Kudron, Jane EB Reusch, Judith G. Regensteiner\",\"doi\":\"10.1101/2024.05.01.24306727\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<strong>Objective</strong> Determine whether statin-associated DM is reported more frequently in women than men in post-marketing adverse drug event (ADE) surveillance.\",\"PeriodicalId\":501419,\"journal\":{\"name\":\"medRxiv - Endocrinology\",\"volume\":\"60 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"medRxiv - Endocrinology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1101/2024.05.01.24306727\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.05.01.24306727","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Sex-differences in reporting of statin-associated diabetes mellitus to the US Food and Drug Administration
Objective Determine whether statin-associated DM is reported more frequently in women than men in post-marketing adverse drug event (ADE) surveillance.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
